Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection

被引:0
|
作者
Wai-Kay Seto
Man-Fung Yuen
James Fung
Ching-Lung Lai
机构
[1] The University of Hong Kong,Department of Medicine
[2] Queen Mary Hospital,undefined
来源
关键词
Hepatitis B; Tenofovir; Resistance; HBeAg; HBsAg; HBV DNA;
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
页码:327 / 334
页数:7
相关论文
共 50 条
  • [31] The Administration of Tenofovir Disoproxil Fumarate for Pregnant Japanese Women with Chronic Hepatitis B
    Suoh, Maito
    Tamori, Akihiro
    Amano-Teranishi, Yuga
    Nakai, Takashi
    Enomoto, Masaru
    Kawasaki, Yasuko
    Kioka, Kiyohide
    Kawada, Norifumi
    INTERNAL MEDICINE, 2020, 59 (02) : 205 - 210
  • [32] Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (01) : 49 - 63
  • [33] Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
    Yim, Hyung Joon
    Kim, Ji Hoon
    Cho, Yong Kyun
    Kweon, Young Oh
    Cho, Hyun Chin
    Hwang, Jae Seok
    Lee, Changhyeong
    Koh, Moon Soo
    Baek, Yang-Hyun
    Park, Young-Min
    Lee, Jeong-Hoon
    Kim, Seung Up
    Kang, Min-Kyu
    Park, Neung Hwa
    Lee, June Sung
    Chon, Young Eun
    Cheon, Gab Jin
    Chae, Hee Bok
    Sohn, Joo Hyun
    Lim, Young-Suk
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 3263 - 3274
  • [34] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive patients with chronic hepatitis B
    Lim, Jihye
    Choi, Won-Mook
    Shim, Ju Hyun
    Lee, Danbi
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    JOURNAL OF HEPATOLOGY, 2022, 77 : S842 - S842
  • [35] AN EFFICACY OF CONTINUING TENOFOVIR DISOPROXIL FUMARATE VERSUS SWITCHING ENTECAVIR TO TENOFOVIR DISOPROXIL FUMARATE IN TREATMENT OF CHRONIC HEPATITIS B PATIENTS: 5-YEAR FOLLOW UP
    Ungtrakul, Teerapat
    Chiersilpa, Kunsuda
    Yingcharoen, Kesinee
    Jiraphairot, Suppawat
    Sangwipasnapaporn, Worrawat
    Dechma, Jiraporn
    Chunnuan, Pitchayachuda
    Kusuman, Pattama
    Pothijaroen, Charinthip
    Tawpa, Jantarika
    Hankla, Pimprapa
    Numahan, Apichayaporn
    Pongpun, Wanwisa
    Soonklang, Kamonwan
    GUT, 2022, 71 : A72 - A72
  • [36] Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B Virus Infection in the African American Community
    Mor, Yechiel
    Wang, Jing
    Rizwan, Aliza
    Badia, Victoria
    Naylor, Paul
    Ehrinpreis, Murray
    Mutchnick, Milton G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S537 - S538
  • [37] Safety of Tenofovir Disoproxil Fumarate Treatment in Late Pregnancy in Highly Viremic Mothers with Chronic Hepatitis B
    Pan, Calvin
    Ta, Anita
    Zeng, Zheng
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S156 - S156
  • [38] Renal Safety of Long-term Tenofovir Disoproxil Fumarate Treatment in Patients With Chronic Hepatitis B
    Woldemedihn, Gezahegn M.
    Aberra, Hanna
    Desalegn, Hailemichael
    Berhe, Nega
    Belay, Denekew Bitew
    Rueegg, Corina S.
    Johannessen, Asgeir
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (08):
  • [39] Comparison of the efficacy of tenofovir disoproxil fumarate and entecavir for initial treatment of patient with chronic hepatitis B in China
    Huang, Mingxing
    Jie, Yusheng
    Shi, Hong
    Li, Xinhua
    Li, Xiangyong
    Wu, Yuankai
    Lin, Guoli
    Chong, Yutian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (01): : 666 - 673
  • [40] Tenofovir disoproxil fumarate treatment is safe and efficacy for chronic hepatitis B mothers from early pregnancy
    Chen, Tianyan
    Feng, Yali
    Liu, Jinfeng
    Yao, Naijuan
    Zhao, Yingren
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E125 - E125